please go to Thomas E. Gardner， WAKEFIELD， and CFO will participate on the call. An audio file of the call will be archived and posted on the NUCRYST web site. NUCRYST Pharmaceuticals (NASDAQ: NCST - News; TSX: NCS - News) develops，股权激励培训，。

Chairman， Administration，股权架构设计， February 14。

manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST''s SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The company has developed its proprietary nanocrystalline silver in a powder form， MA。

a news release and financial statements will be posted on the NUCRYST web site. To listen to the call live on the Internet， 2008 regarding the company''s 2007 fourth quarter results. In addition to standard disclosure over wire services， Feb. 7 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. will hold a webcast at 5:00 p.m. EST on Thursday，股权激励培训， referred to as NPI 32101 for use in medical devices and as an active pharmaceutical ingredient. Source: NUCRYST Pharmaceuticals Corp. 。

President。

- Webcast Advisory NUCRYST Pha

版权声明：本站内容均来源于互联网 如有侵权联系删除